The Defense Logistics Agency issued a $1,625.52 delivery order to Amerisourcebergen Drug Corp on March 24, 2026, for XCOPRI 25 mg tablets (30-count). The order is placed under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price and an...
The Defense Logistics Agency issued a $3,448.92 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for XCOPRI 25 mg tablets (30-count supply), with ultimate completion by March 2, 2026. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies globally to support military healthcare programs. Place of performance is Conshohocken, PA....
The Defense Logistics Agency issued a $4,040.86 delivery order to Amerisourcebergen Drug Corp on March 16, 2026, for XCOPRI 100 mg tablets (30-count package). The order is issued under the parent indefinite delivery contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical supplies to military healthcare programs...
<p>The Defense Logistics Agency issued a $5,317.06 delivery order to AmerisourceBergen Drug Corp on March 23, 2026, for XCOPRI 150 mg tablets (30-count).</p>
<p>The order is issued under the DLA Troop Support Medical indefinite delivery contract SPE2DX, a global pharmaceutical supply vehicle valued at up to $999,999,999 through December 2026. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure with an ultimate completion date of March 24, 2026.</p>
<p>The Defense Logistics Agency issued a $1,760.57 delivery order to AmerisourceBergen Drug Corp on March 25, 2026, for XCOPRI 50 mg tablets (30-count packages). Place of performance is Conshohocken, PA. The order carries a firm fixed price structure with an ultimate completion date of March 26, 2026.</p>
<p>The Defense Logistics Agency issued a $2,158.71 delivery order to Amerisourcebergen Drug Corp on March 26, 2026, for XCOPRI 100 mg tablets (30-count). Place of performance is Conshohocken, PA. The order has a firm fixed price and an ultimate completion date of March 27, 2026.</p>
<p>The Defense Logistics Agency issued a $2,282.76 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for XCOPRI 25 mg tablets (30-count package).</p>
<p>Place of performance is Conshohocken, PA. Ultimate completion date is March 2, 2026. The order is priced firm fixed and carries no set-aside designation.</p>
<p>The Defense Logistics Agency issued a $3,059.88 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for XCOPRI 200 mg tablets (30-count).</p>
<p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 6, 2026. No set-aside was used.</p>
<p>The Defense Logistics Agency issued a $2,250.49 delivery order to Amerisourcebergen Drug Corp on February 23, 2026, for XCOPRI 25 mg tablets (30-count).</p>
<p>Place of performance is Conshohocken, PA. The order ceiling value is $2,250.49 with an ultimate completion date of February 24, 2026. Pricing is firm fixed price. No set-aside was used.</p>
<p>The Defense Logistics Agency issued a $17,430.24 delivery order to AmerisourceBergen Drug Corp on April 3, 2026, for XCOPRI 50 mg tablets (30-count supply). Place of performance is Conshohocken, PA. The order is priced firm fixed price with an ultimate completion date of April 6, 2026. No set-aside was used.</p>